Page last updated: 2024-12-08
oxoline
Description
naphthalene-1,2,3,4-tetrone : A member of the class of tetralins that is tetralin in which oxo groups replace the hydrogens at positions 1, 2, 3, and 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 169137 |
| CHEBI ID | 78854 |
| SCHEMBL ID | 6050558 |
| MeSH ID | M0043934 |
Synonyms (24)
| Synonym |
|---|
| STL290460 |
| naphthalenetetrone |
| 30266-58-1 |
| EC-000.1434 |
| oxoline , |
| 1,2,3,4-naphthalenetetrone |
| AKOS004115507 |
| naphthalene-1,2,3,4-tetrone |
| unii-m9fiq15q9n |
| tetraoxotetrahydronaphthalene dihydrate |
| m9fiq15q9n , |
| naphthalene-1,2,3,4-tetraone |
| FT-0606207 |
| 1,2,3,4-tetrahydro-1,2,3,4-tetraoxonaphthalene |
| CHEBI:78854 |
| SCHEMBL6050558 |
| 1,2,3,4-tetraoxo-1,2,3,4-tetrahydronaphthalenedihydrate |
| oxolin [who-dd] |
| oxolin |
| 1,2,3,4-tetraoxotetralin |
| 1,2,3,4-tetraketotetralin |
| 1,2,3,4-tetraoxo-1,2,3,4-tetrahydronaphthalene |
| DTXSID00184354 |
| Q4332935 |
Roles (1)
| Role | Description |
|---|
| geroprotector | Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| tetralins | Compounds containing a tetralin skeleton. |
| aromatic ketone | A ketone in which the carbonyl group is attached to an aromatic ring. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 36.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 36.31 (24.57) | | Research Supply Index | 2.56 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 50.33 (26.88) | | Search Engine Supply Index | 2.16 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |